⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SDGR News
Schrodinger, Inc. Common Stock
Form 8-K
sec.gov
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Form 8-K
sec.gov
SDGR
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
globenewswire.com
SDGR
Form 8-K
sec.gov
SDGR
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035
globenewswire.com
CERT
SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SDGR
Form 8-K
sec.gov
SDGR
Form 8-K
sec.gov
SDGR
Schrödinger to Participate in Upcoming Investor Conferences
businesswire.com
SDGR